Published in Cancer Res on September 15, 1991
Targeting DNA topoisomerase II in cancer chemotherapy. Nat Rev Cancer (2009) 5.06
BLM is required for faithful chromosome segregation and its localization defines a class of ultrafine anaphase bridges. EMBO J (2007) 3.22
Antitumor bisdioxopiperazines inhibit yeast DNA topoisomerase II by trapping the enzyme in the form of a closed protein clamp. Proc Natl Acad Sci U S A (1994) 1.84
Mammalian DNA topoisomerase IIIalpha is essential in early embryogenesis. Proc Natl Acad Sci U S A (1998) 1.76
Oxidative stress, redox signaling, and metal chelation in anthracycline cardiotoxicity and pharmacological cardioprotection. Antioxid Redox Signal (2012) 1.37
Inhibition of DNA topoisomerase II by ICRF-193 induces polyploidization by uncoupling chromosome dynamics from other cell cycle events. J Cell Biol (1994) 1.36
Topoisomerase II can unlink replicating DNA by precatenane removal. EMBO J (2001) 1.30
The cell cycle-coupled expression of topoisomerase IIalpha during S phase is regulated by mRNA stability and is disrupted by heat shock or ionizing radiation. Mol Cell Biol (1996) 1.28
Selective inhibition of topoisomerases from Pneumocystis carinii compared with that of topoisomerases from mammalian cells. Antimicrob Agents Chemother (1994) 1.18
A mitotic topoisomerase II checkpoint in budding yeast is required for genome stability but acts independently of Pds1/securin. Genes Dev (2006) 1.07
Inhibition of topoisomerase II by ICRF-193 prevents efficient replication of herpes simplex virus type 1. J Virol (1996) 1.04
Chromosomes with two intact axial cores are induced by G2 checkpoint override: evidence that DNA decatenation is not required to template the chromosome structure. J Cell Biol (1997) 1.01
A topoisomerase II-dependent mechanism for resetting replicons at the S-M-phase transition. Genes Dev (2008) 0.99
DNA damage signaling in hematopoietic cells: a role for Mre11 complex repair of topoisomerase lesions. Cancer Res (2008) 0.97
High throughput screening for small molecule enhancers of the interferon signaling pathway to drive next-generation antiviral drug discovery. PLoS One (2012) 0.93
Canonical non-homologous end joining in mitosis induces genome instability and is suppressed by M-phase-specific phosphorylation of XRCC4. PLoS Genet (2014) 0.93
Protein kinase C delta activates topoisomerase IIalpha to induce apoptotic cell death in response to DNA damage. Mol Cell Biol (2006) 0.92
Mammalian Fbh1 is important to restore normal mitotic progression following decatenation stress. DNA Repair (Amst) (2010) 0.91
Iron chelators with topoisomerase-inhibitory activity and their anticancer applications. Antioxid Redox Signal (2012) 0.91
Revised genetic requirements for the decatenation G2 checkpoint: the role of ATM. Cell Cycle (2010) 0.85
Rad9A is required for G2 decatenation checkpoint and to prevent endoreduplication in response to topoisomerase II inhibition. J Biol Chem (2010) 0.85
Effect of ICRF-193, a novel DNA topoisomerase II inhibitor, on simian virus 40 DNA and chromosome replication in vitro. Mol Cell Biol (1992) 0.84
G226, a new epipolythiodioxopiperazine derivative, triggers DNA damage and apoptosis in human cancer cells in vitro via ROS generation. Acta Pharmacol Sin (2014) 0.82
An improved high yield total synthesis and cytotoxicity study of the marine alkaloid neoamphimedine: an ATP-competitive inhibitor of topoisomerase IIα and potent anticancer agent. Mar Drugs (2014) 0.81
MT7, a novel compound from a combinatorial library, arrests mitosis via inhibiting the polymerization of microtubules. Invest New Drugs (2009) 0.81
Response to ICRF-159 in cell lines resistant to cleavable complex-forming topoisomerase II inhibitors. Br J Cancer (1997) 0.80
Catalytic inhibitors of topoisomerase II differently modulate the toxicity of anthracyclines in cardiac and cancer cells. PLoS One (2013) 0.80
Hypersensitivity of Ku-deficient cells toward the DNA topoisomerase II inhibitor ICRF-193 suggests a novel role for Ku antigen during the G2 and M phases of the cell cycle. Mol Cell Biol (1998) 0.80
Direct observation of strand passage by DNA-topoisomerase and its limited processivity. PLoS One (2012) 0.80
Induction of thrombospondin-1 partially mediates the anti-angiogenic activity of dexrazoxane. Br J Cancer (2009) 0.79
Drug transporter-independent liver cancer cell killing by a marine steroid methyl spongoate via apoptosis induction. J Biol Chem (2011) 0.78
Characterisation of cytotoxicity and DNA damage induced by the topoisomerase II-directed bisdioxopiperazine anti-cancer agent ICRF-187 (dexrazoxane) in yeast and mammalian cells. BMC Pharmacol (2004) 0.78
Hypoxia-Targeted Drug Q6 Induces G2-M Arrest and Apoptosis via Poisoning Topoisomerase II under Hypoxia. PLoS One (2015) 0.78
The radiation response of sarcomas by histologic subtypes: a review with special emphasis given to results achieved with razoxane. Sarcoma (2006) 0.78
TOP2 synergizes with BAF chromatin remodeling for both resolution and formation of facultative heterochromatin. Nat Struct Mol Biol (2017) 0.77
D11, a novel glycosylated diphyllin derivative, exhibits potent anticancer activity by targeting topoisomerase IIα. Invest New Drugs (2010) 0.77
Defining a genotoxic profile with mouse embryonic stem cells. Exp Biol Med (Maywood) (2013) 0.75
The effects of ICRF-154 in combination with other anticancer agents in vitro. Br J Cancer (1992) 0.75
Combined vindesine and razoxane shows antimetastatic activity in advanced soft tissue sarcomas. Clin Exp Metastasis (2007) 0.75
Structure and organization of the hepatitis C virus genome isolated from human carriers. J Virol (1991) 8.33
Single- and multiple-dose pharmacokinetics of AM-1155, a new 6-fluoro-8-methoxy quinolone, in humans. Antimicrob Agents Chemother (1995) 2.12
Effects of Aspergillus fumigatus culture filtrate on antifungal activity of human phagocytes in vitro. Thorax (1998) 2.00
Antitumor bisdioxopiperazines inhibit yeast DNA topoisomerase II by trapping the enzyme in the form of a closed protein clamp. Proc Natl Acad Sci U S A (1994) 1.84
Characterization of a mammalian mutant with a camptothecin-resistant DNA topoisomerase I. Proc Natl Acad Sci U S A (1987) 1.72
The synthesis of protein(s) for chromosome condensation may be regulated by a post-transcriptional mechanism. J Cell Physiol (1981) 1.71
Search for supersymmetry using final states with one lepton, jets, and missing transverse momentum with the ATLAS detector in √s=7 TeV pp collisions. Phys Rev Lett (2011) 1.60
Suppressor gene Su3+ of E. coli, a structural gene for tyrosine TRNA. Proc Natl Acad Sci U S A (1968) 1.57
RP58 associates with condensed chromatin and mediates a sequence-specific transcriptional repression. J Biol Chem (1998) 1.50
Observation of a centrality-dependent dijet asymmetry in lead-lead collisions at sqrt[S(NN)] =2.76 TeV with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.41
Measurement of dijet azimuthal decorrelations in pp collisions at sqrt(s)=7 TeV. Phys Rev Lett (2011) 1.39
Breast cancer resistance protein directly confers SN-38 resistance of lung cancer cells. Biochem Biophys Res Commun (2001) 1.39
Potent antitumor activity of MS-247, a novel DNA minor groove binder, evaluated by an in vitro and in vivo human cancer cell line panel. Cancer Res (1999) 1.37
Inhibition of DNA topoisomerase II by ICRF-193 induces polyploidization by uncoupling chromosome dynamics from other cell cycle events. J Cell Biol (1994) 1.36
Determination of the strange-quark density of the proton from ATLAS measurements of the W→ℓν and Z→ℓℓ cross sections. Phys Rev Lett (2012) 1.34
The prevalence of developmental anomalies of teeth and their association with tooth size in the primary and permanent dentitions of 1650 Japanese children. Int J Paediatr Dent (1996) 1.34
Inhibition of intracellular topoisomerase II by antitumor bis(2,6-dioxopiperazine) derivatives: mode of cell growth inhibition distinct from that of cleavable complex-forming type inhibitors. Cancer Res (1991) 1.34
Search for new particles in two-jet final states in 7 TeV proton-proton collisions with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.32
canoe encodes a novel protein containing a GLGF/DHR motif and functions with Notch and scabrous in common developmental pathways in Drosophila. Genes Dev (1995) 1.31
Catalytic inhibitors of DNA topoisomerase II. Biochim Biophys Acta (1998) 1.30
Observation of associated near-side and away-side long-range correlations in sqrt[s(NN)]=5.02 TeV proton-lead collisions with the ATLAS detector. Phys Rev Lett (2013) 1.27
Susceptibility of Fanconi's anemia lymphoblasts to DNA-cross-linking and alkylating agents. Cancer Res (1982) 1.24
Suppressive effects of Aspergillus fumigatus culture filtrates on human alveolar macrophages and polymorphonuclear leucocytes. Eur Respir J (1996) 1.24
Chronic cyclosporine nephropathy: the Achilles' heel of immunosuppressive therapy. Kidney Int (1996) 1.22
Formation and fate of abnormal ribosomes of E. coli cells treated with 5-fluorouracil. Proc Natl Acad Sci U S A (1965) 1.20
Search for dark matter candidates and large extra dimensions in events with a photon and missing transverse momentum in pp collision data at sqrt[s]=7 TeV with the ATLAS detector. Phys Rev Lett (2013) 1.19
Increased DNA chain breakage by combined action of bleomycin and superoxide radical. Biochem Biophys Res Commun (1975) 1.16
Characterization of a camptothecin-resistant human DNA topoisomerase I. J Biol Chem (1988) 1.16
Development of hyperthyroidism following primary hypothyroidism: a case report with changes in thyroid-related antibodies. Clin Endocrinol (Oxf) (1988) 1.15
Search for a supersymmetric partner to the top quark in final states with jets and missing transverse momentum at sqrt[s] = 7 TeV with the ATLAS detector. Phys Rev Lett (2012) 1.13
Differential activation of brain-derived neurotrophic factor gene promoters I and III by Ca2+ signals evoked via L-type voltage-dependent and N-methyl-D-aspartate receptor Ca2+ channels. J Biol Chem (2000) 1.08
The DNA binding activity of Translin is mediated by a basic region in the ring-shaped structure conserved in evolution. FEBS Lett (1999) 1.08
Studies on a new 1,5-benzothiazepine derivative (CRD-401). 3. Effects of optical isomers of CRD-401 on smooth muscle and other pharmacological properties. Jpn J Pharmacol (1972) 1.08
Search for tb resonances in proton-proton collisions at √s=7 TeV with the ATLAS detector. Phys Rev Lett (2012) 1.07
Isolation and characterization of a cDNA encoding a Translin-like protein, TRAX. FEBS Lett (1997) 1.07
High levels of circulating interleukin-4 and interleukin-10 in Kawasaki disease. Int Arch Allergy Immunol (1997) 1.06
Human immunodeficiency virus type 1 reverse transcriptase: enhancement of activity by interaction with cellular topoisomerase I. Proc Natl Acad Sci U S A (1995) 1.06
Evaluation of the antioxidant activity of environmental plants: activity of the leaf extracts from seashore plants. J Agric Food Chem (1999) 1.05
The role of angiogenic and wound repair factors during CMV-accelerated transplant vascular sclerosis in rat cardiac transplants. Am J Transplant (2007) 1.05
Renal cholesterol accumulation: a durable response after acute and subacute renal insults. Am J Pathol (2001) 1.05
Search for a light Higgs boson decaying to long-lived weakly interacting particles in proton-proton collisions at sqrt[s] = 7 TeV with the ATLAS detector. Phys Rev Lett (2012) 1.05
Mechanism of O2- generation in reduction and oxidation cycle of ubiquinones in a model of mitochondrial electron transport systems. Biochim Biophys Acta (1988) 1.04
Inhibitory effect of Ephedrae herba, an oriental traditional medicine, on the growth of influenza A/PR/8 virus in MDCK cells. Antiviral Res (1999) 1.03
Rapid purification and characterization of DNA topoisomerase I from cultured mouse mammary carcinoma FM3A cells. J Biol Chem (1983) 1.03
Transport of 7-ethyl-10-hydroxycamptothecin (SN-38) by breast cancer resistance protein ABCG2 in human lung cancer cells. Biochem Biophys Res Commun (2001) 1.03
Studies on biologically active halogenated compounds. 1. Synthesis and central nervous system depressant activity of 2-(fluoromethyl)-3-aryl-4(3H)-quinazolinone derivatives. J Med Chem (1979) 1.02
Study of quantitative oral radioactivity in salivary gland scintigraphy and determination of the clinical stage of Sjögren's syndrome. J Nucl Med (2001) 1.00
Isolation and purification of calcium and magnesium dependent endonuclease from rat liver nuclei. Biochem Biophys Res Commun (1974) 1.00
Effects of ketamine and propofol on inflammatory responses of primary glial cell cultures stimulated with lipopolysaccharide. Br J Anaesth (2005) 0.99
Search for supersymmetry in events with three leptons and missing transverse momentum in √[s]=7 TeV pp collisions with the ATLAS detector. Phys Rev Lett (2012) 0.99
A possible immunosuppressant, cycloprodigiosin hydrochloride, obtained from Pseudoalteromonas denitrificans. Biochem Biophys Res Commun (1997) 0.99
Correlation between magnetic resonance imaging and histopathology of intracranial glioma. Neurol Res (1991) 0.99
[Functions of the transforming growth factor-beta superfamily in eyes]. Nippon Ganka Gakkai Zasshi (1997) 0.99
Structural analysis of a developmentally regulated 25-kDa protein gene of Sarcophaga peregrina. J Biochem (1985) 0.98
Cellular proliferation and macrophage influx precede interstitial fibrosis in cyclosporine nephrotoxicity. Kidney Int (1995) 0.98
In vitro release of thymine from DNA by neocarzinostatin. Biochem Biophys Res Commun (1976) 0.97
Insulin-like growth factor-I ameliorates transient ischemia-induced acute renal failure in rats. J Pharmacol Exp Ther (1993) 0.96
Different behavior towards raw starch of three forms of glucoamylase from a Rhizopus sp. J Biochem (1985) 0.96
Induction of necrosis by zinc in prostate carcinoma cells and identification of proteins increased in association with this induction. Eur J Biochem (1998) 0.96
Mechanism of inhibition of mammalian DNA topoisomerase I by heparin. Biochem J (1987) 0.95
Dissecting and fusiform aneurysms of vertebro-basilar systems. MR imaging. Neuroradiology (1990) 0.95
Surgical treatment of cavernous angioma involving the brainstem and review of the literature. Acta Neurochir (Wien) (1991) 0.94
Toxicokinetic study of norfloxacin-induced arthropathy in juvenile animals. Toxicol Appl Pharmacol (1990) 0.94
Bone mineral density differences between paraplegic and quadriplegic patients: a cross-sectional study. Spinal Cord (1999) 0.93
Successful perioperative management of a patient with Parkinson's disease by enteral levodopa administration under propofol anesthesia. Anesthesiology (1998) 0.93
Allodynia and hyperalgesia induced by herpes simplex virus type-1 infection in mice. Pain (2000) 0.92
Pharmacological studies on 6-amino-2-fluoromethyl-3-(O-tolyl)-4(3H)-quinazolinone (afloqualone), a new centrally acting muscle relaxant. (II) Effects on the spinal reflex potential and the rigidity. Jpn J Pharmacol (1982) 0.91
The relationship between moyamoya disease and bacterial infection. Clin Neurol Neurosurg (1997) 0.91
DNA topoisomerase II is the molecular target of bisdioxopiperazine derivatives ICRF-159 and ICRF-193 in Saccharomyces cerevisiae. Cancer Res (1995) 0.91
Randomized clinical trial: rikkunshito in the treatment of functional dyspepsia--a multicenter, double-blind, randomized, placebo-controlled study. Neurogastroenterol Motil (2014) 0.91
[Anatomical study of the thoracic duct and its valve in the human adult]. Kaibogaku Zasshi (1984) 0.90
Comparison of the effects of convulsant and depressant barbiturate stereoisomers on AMPA-type glutamate receptors. Anesthesiology (1999) 0.90
Fluorescence digital image analysis of serotonin-induced calcium oscillations in single blood platelets. Cell Calcium (1991) 0.90
Functional evaluation with intravoxel incoherent motion echo-planar MRI in irradiated salivary glands: a correlative study with salivary gland scintigraphy. J Magn Reson Imaging (2001) 0.89
Collateral drug sensitivity induced in CPT-11 (a novel derivative of camptothecin)-resistant cell lines. Biomed Pharmacother (1990) 0.89
Clinical analysis of recurrent subarachnoid hemorrhage after neck clipping surgery. Neurol Med Chir (Tokyo) (1997) 0.89
HTLV-1 tax oncoprotein binds to DNA topoisomerase I and inhibits its catalytic activity. Virology (2000) 0.89
Nonstereoselective inhibition of neuronal nicotinic acetylcholine receptors by ketamine isomers. Anesth Analg (2000) 0.89
Cell death-associated translocation of plasma membrane components induced by CTL. J Immunol (2000) 0.89
Cyclosporine A induced arteriolopathy in a rat model of chronic cyclosporine nephropathy. Kidney Int (1995) 0.88
Skull metastasis of Ewing's sarcoma--three case reports. Neurol Med Chir (Tokyo) (1999) 0.88
The effects of ketamine and propofol on neuronal nicotinic acetylcholine receptors and P2x purinoceptors in PC12 cells. Anesth Analg (1999) 0.88
Studies on cytomegalovirus and Epstein-Barr virus infection in moyamoya disease. Clin Neurol Neurosurg (1997) 0.87
Zinc induces mixed types of cell death, necrosis, and apoptosis, in molt-4 cells. J Biochem (2000) 0.87
Daily fecal sex steroid hormonal changes and mating success in captive female cheetahs (Acinonyx jubatus) in Japan. Anim Reprod Sci (2011) 0.87
Inhibition of topoisomerase I by heparin. Biochem Biophys Res Commun (1982) 0.86
Measurement of the ZZ production cross section and limits on anomalous neutral triple gauge couplings in proton-proton collisions at sqrt[s] = 7 TeV with the ATLAS detector. Phys Rev Lett (2012) 0.86
Neuroprotective strategies in Parkinson's disease: protection against progressive nigral damage induced by free radicals. Neurotox Res (2000) 0.86
Supercoiled DNA folded by nonhistone proteins in cultured mouse carcinoma cells. J Biochem (1978) 0.86
Synthesis and central nervous system actions of thyrotropin-releasing hormone analogues containing a dihydroorotic acid moiety. J Med Chem (1990) 0.86
Changes in muscle strength properties caused by harvesting of autogenous semitendinosus tendon for reconstruction of contralateral anterior cruciate ligament. Arthroscopy (1998) 0.86
Propofol formulated with long-/medium-chain triglycerides reduces the pain of injection by target controlled infusion. Acta Anaesthesiol Scand (2006) 0.85
[Clinical survey of caries incidence in children with cleft lip and palate]. Shoni Shikagaku Zasshi (1989) 0.85
Search for gluinos in events with two same-sign leptons, jets, and missing transverse momentum with the ATLAS detector in pp collisions at sqrt[s]=7 TeV. Phys Rev Lett (2012) 0.85
Topical tranilast for treatment of the early stage of mild dry eye associated with chronic GVHD. Bone Marrow Transplant (2009) 0.85
Overcoming CPT-11 resistance by using a biscoclaurine alkaloid, cepharanthine, to modulate plasma trans-membrane potential. Int J Cancer (1997) 0.85